Pre- and postnatal stimulation of pulmonary surfactant protein D by in vivo dexamethasone treatment of rats

Life Sciences

Volumn 50, Issue 23, 1992, Pages 1761-1767

  Ogasawara, Yoshinori ^a   Kuroki, Yoshio ^a   Tsuzuki, Akihiro ^a   Ueda, Shigeru ^b   Misaki, Hideo ^b   Akino, Toyoaki ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Asahi Chemical Industry Corporated   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; SURFACTANT ASSOCIATED PROTEIN;

AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DEVELOPMENT; FETUS; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMAL; ANIMALS, NEWBORN; BODY WEIGHT; COMPARATIVE STUDY; DEXAMETHASONE; EMBRYO AND FETAL DEVELOPMENT; FEMALE; FETUS; GLYCOPROTEINS; LUNG; ORGAN WEIGHT; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPIDS; PREGNANCY; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RATS; RATS, INBRED STRAINS; STIMULATION, CHEMICAL;

ANIMALIA;

EID: 0026507566     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(92)90059-X     Document Type: Article

References (34)

1. Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells.
2. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A.
3. Increases in the 35kDa surfactant-associated protein and its mRNA followingin vivo dexamethasone treatment of fetal and neonatal rats